Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.09 - $19.38 $434,430 - $523,260
-27,000 Reduced 69.95%
11,600 $201,000
Q1 2024

May 15, 2024

BUY
$18.97 - $23.71 $470,456 - $588,008
24,800 Added 179.71%
38,600 $756,000
Q4 2023

Feb 14, 2024

SELL
$20.42 - $24.22 $98,016 - $116,256
-4,800 Reduced 25.81%
13,800 $317,000
Q3 2023

Nov 14, 2023

SELL
$21.63 - $27.92 $34,608 - $44,672
-1,600 Reduced 7.92%
18,600 $427,000
Q2 2023

Aug 14, 2023

BUY
$24.01 - $29.93 $48,020 - $59,860
2,000 Added 10.99%
20,200 $527,000
Q1 2023

May 15, 2023

BUY
$21.0 - $28.71 $212,100 - $289,971
10,100 Added 124.69%
18,200 $502,000
Q4 2022

Feb 14, 2023

BUY
$22.29 - $35.91 $46,809 - $75,411
2,100 Added 35.0%
8,100 $183,000
Q3 2022

Nov 14, 2022

BUY
$28.9 - $42.97 $173,400 - $257,820
6,000 New
6,000 $204,000

Others Institutions Holding PRVA

About Privia Health Group, Inc.


  • Ticker PRVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 111,326,000
  • Market Cap $2.14B
  • Description
  • Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population...
More about PRVA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.